Home/Filings/4/0001104659-22-097017
4//SEC Filing

Derby Michael 4

Accession 0001104659-22-097017

CIK 0001811623other

Filed

Aug 31, 8:00 PM ET

Accepted

Sep 1, 4:06 PM ET

Size

6.0 KB

Accession

0001104659-22-097017

Insider Transaction Report

Form 4
Period: 2022-08-30
Derby Michael
DirectorExecutive Chairman10% Owner
Transactions
  • Purchase

    Common Stock

    2022-08-30$5.25/sh+95,000$498,7507,336,745 total(indirect: By LLC)
Holdings
  • Common Stock

    361,000
Footnotes (3)
  • [F1]Includes restricted stock units that vest as described in the Company's Registration Statement on Form S-1 (File No. 333-239676).
  • [F2]These shares were purchased from the underwriters by TardiMed Sciences, LLC ("TardiMed") in the issuer's initial public offering, which closed on August 30, 2022. See footnote 3 for the reporting person's relationship to TardiMed.
  • [F3]The reporting person is the Managing Partner of TardiMed and has sole voting and dispositive control over the shares of Common Stock held by the entity. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Issuer

PaxMedica, Inc.

CIK 0001811623

Entity typeother

Related Parties

1
  • filerCIK 0001809613

Filing Metadata

Form type
4
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 4:06 PM ET
Size
6.0 KB